Zhaoke Ophthalmology Limited Entering an Exclusive Distribution and Promotion Agreement with Pharmentum Biopharmato to Commercialize Epinastine Hydrochloride Eye Drops in China (Excluding Hong Kong, Macau and Taiwan)

Zhaoke's Innovative Presbyopia Drug YUVEZZI™ Approved in Macau

Zhaoke Ophthalmology Acquires the Global Rights of Atropine Sulfate Eye Drops, an Innovative Drug for Myopia Progression Control

Zhaoke's Innovative Presbyopia Drug, YUVEZZI™ Approved for Use at Boao Super Hospital in Hainan, China, as a Clinically Urgent Imported Drug

Accelerating Global Layout | Zhaoke Ophthalmology Debuts at BIO 2026 and Signs Strategic MOU with Teuto of Brazil